Considering that serum albumin is synthesized exclusively by hepatocytes and that its levels tend to decrease in chronic liver diseases and in cases of severe acute liver damage [49], the results obtained indicate that LQM755 could be a promising drug for the treatment of hepatic cholestasis; therefore, further studies will be required in cholestasis models, such as the bile duct ligation model in rats. The gene discussed is ALB; the disease is cholestasis.